WISH-PC2: A unique xenograft model of human prostatic small cell carcinoma

Cancer Research

Volumn 60, Issue 23, 2000, Pages 6563-6567

  Pinthus, J H ^a   Waks, T ^a   Schindler, D G ^a   Harmelin, A ^a   Said, J W ^a   Belldegrun, A ^a   Ramon, J ^a   Eshhar, Z ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BICALUTAMIDE; CHROMOGRANIN A; EPITHELIAL MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN;

AGED; ARTICLE; ECHOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SMALL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR XENOGRAFT;

ADENOCARCINOMA; AGED; ANIMALS; CARCINOMA, SMALL CELL; CELL DIFFERENTIATION; CELL DIVISION; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; PHENOTYPE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034544604     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chemotherapy for small cell carcinoma of prostatic origin
2. Small cell carcinoma of the bladder and prostate
3. Stem cell genes in androgen-independent prostate cancer
4. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: A review of morphologic aspects
5. Neuroendocrine differentiation in prostatic carcinoma
6. The inhibition of the paracrine progression of prostate cancer as an approach to early therapy of prostatic carcinoma
7. Overexpression of human epidermal growth factor receptor and cerbB-2 by neuroendocrine cells in normal prostatic tissue
8. The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: A review and future directions in basic research
9. Xenografted small cell undifferentiated cancer of prostate: Possible common origin with prostatic adenocarcinoma
10. Site-specific growth of the prostate xenograft line UCRU-PR-2
11. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors
12. Metastatic model for human prostate cancer using orthotopic implantation in nude mice
13. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
14. Can microwave antigen retrieval replace frozen section immunohistochemistry in the phenotyping of lymphoid neoplasm? A comparative study of κ and λ light chain staining in frozen sections, B5-fixed paraffin sections, and microwave urea nitrogen retrieval
15. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications
16. The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study
17. Frequent development of murine T-cell lymphomas with TcR α/β+, CD4-/8- phenotype after implantation of human inflammatory breast cancer cells in BALB/c nude mice
18. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
19. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts
20. Metastatic models of human cancer xenografted in the nude mouse: The importance of orthotopic transplantation
21. Prostate cancer: Management of hormone refractory disease neuroendocrine progression
22. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family
23. STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors
24. Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model
25. Small cell carcinoma of prostate: Effectiveness of hormonal versus chemotherapy